Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koon Teo

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 30, 2013
Maternal and newborn health profile in a first nations community in CanadaAndre P Oliveira, Saurabh Kalra, Gita Wahi, et al.
Circulation|September 23, 2009
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular DiseasePaolo Verdecchia, Peter Sleight, Giuseppe Mancia, et al.
Journal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.
American Journal of Hypertension|December 20, 2015
Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin AmericansPablo M Lamelas, Andrew Mente, Rafael Diaz, et al.
Journal of Hypertension|April 13, 2012
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studiesPaolo Verdecchia, Gilles Dagenais, Jeff Healey, et al.
Hypertension (Dallas, Tex. : 1979)|October 17, 2012
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)Giuseppe Mancia, Gianfranco Parati, Grzegorz Bilo, et al.
Plos Medicine|June 1, 2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysisAna-Catarina Pinho-Gomes, Luis Azevedo, Emma Copland, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
JAMA Network Open|April 10, 2025
Trajectory of Early Life Adiposity Among South Asian ChildrenSandi M Azab, Saba Naqvi, Talha Rafiq, et al.
American Heart Journal|October 21, 2018
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductPhilip Joseph, Prem Pais, Antonio L Dans, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|October 30, 2013
Maternal and newborn health profile in a first nations community in CanadaAndre P Oliveira, Saurabh Kalra, Gita Wahi, et al.
Circulation|September 23, 2009
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular DiseasePaolo Verdecchia, Peter Sleight, Giuseppe Mancia, et al.
Journal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.
American Journal of Hypertension|December 20, 2015
Association of Urinary Sodium Excretion With Blood Pressure and Cardiovascular Clinical Events in 17,033 Latin AmericansPablo M Lamelas, Andrew Mente, Rafael Diaz, et al.
Journal of Hypertension|April 13, 2012
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studiesPaolo Verdecchia, Gilles Dagenais, Jeff Healey, et al.
Hypertension (Dallas, Tex. : 1979)|October 17, 2012
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)Giuseppe Mancia, Gianfranco Parati, Grzegorz Bilo, et al.
Plos Medicine|June 1, 2021
Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysisAna-Catarina Pinho-Gomes, Luis Azevedo, Emma Copland, et al.
Lancet (London, England)|April 26, 2026
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysisGuyu Zeng, Zeinab Bidel, Qianqian Yang, et al.
JAMA Network Open|April 10, 2025
Trajectory of Early Life Adiposity Among South Asian ChildrenSandi M Azab, Saba Naqvi, Talha Rafiq, et al.
American Heart Journal|October 21, 2018
The International Polycap Study-3 (TIPS-3): Design, baseline characteristics and challenges in conductPhilip Joseph, Prem Pais, Antonio L Dans, et al.
Pageof 18